Plasma membrane mediated action of progesterone in amphibian (Rana dybowskii) oocyte maturation.
The mechanism of progesterone action within the ovarian follicle was investigated in Rana dybowskii, by using immobilized progesterone. Fluorescein isothiocyanate-labeled progesterone 3-O-carboxymethyloxime-BSA (P-BSA) was localized on the outside surface of the denuded oocyte, which indicated that P-BSA did not cross the barrier of cell surface. Progesterone-BSA induced germinal vesicle breakdown (GVBD) of denuded oocytes in a dose-dependent manner but failed to induce GVBD of follicle wall-enclosed oocytes. The time course of P-BSA-induced GVBD in denuded oocytes was similar to that observed with progesterone. Furthermore, both P-BSA and progesterone induced oocyte maturation in the presence of RU486, a well-known nuclear progesterone receptor antagonist. Treatment of denuded oocytes with P-BSA resulted in a threefold increase in inositol triphosphate (IP3) and a fourfold increase in diacylglycerol levels within 10 min. Additionally protein kinase C (PKC) activity was markedly increased by 30 min of incubation following exposure to P-BSA. Such changes were not observed in denuded oocytes exposed to beta-estradiol-6-O-carboxymethyloxime-BSA, which failed to induce GVBD. These results suggest that progesterone acts initially at the oocyte surface where it triggers generation of membrane-mediated second messengers during oocyte maturation in amphibians.
Bandyopadhyay
A
A
Department of Biology, Chonnam National University, Kwangju, 500-757, Republic of Korea.
Bandyopadhyay
J
J
Choi
H H
HH
Choi
H S
HS
Kwon
H B
HB
D000818:Animals; D002462:Cell Membrane / Q000378:metabolism / Q000502:physiology; D002467:Cell Nucleus / Q000378:metabolism; D002478:Cells, Cultured; D005576:Colforsin / Q000494:pharmacology; D004789:Enzyme Activation / Q000187:drug effects; D004958:Estradiol / Q000031:analogs & derivatives / Q000494:pharmacology; D005260:Female; D016650:Fluorescein-5-isothiocyanate / Q000031:analogs & derivatives / Q000494:pharmacology; D015735:Mifepristone / Q000494:pharmacology; D009865:Oocytes / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology*; D006080:Ovarian Follicle / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D011374:Progesterone / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D011493:Protein Kinase C / Q000378:metabolism; D011898:Ranidae; D011980:Receptors, Progesterone / Q000037:antagonists & inhibitors; D015290:Second Messenger Systems / Q000187:drug effects; D012710:Serum Albumin, Bovine / Q000378:metabolism / Q000494:pharmacology*; D013739:Testosterone / Q000031:analogs & derivatives / Q000494:pharmacology
D011980:Receptors, Progesterone; C043089:estradiol 6-O-carboxymethyloxime-bovine serum albumin-fluorescein isothiocyanate; C075151:progesterone 3-(O-carboxymethyl)oxime-bovine serum albumin; C045037:testosterone-3-carboxymethyloxime-bovine serum albumin conjugate; D005576:Colforsin; D012710:Serum Albumin, Bovine; D015735:Mifepristone; D013739:Testosterone; D011374:Progesterone; D004958:Estradiol; D011493:Protein Kinase C; D016650:Fluorescein-5-isothiocyanate